1349 — Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$3.41bn
- HK$2.16bn
- CNY709.40m
- 77
- 20
- 10
- 23
Annual cashflow statement for Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -168 | -210 | -258 | -282 | -321 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 113 | 269 | 165 | 71 | -16.5 |
| Capital Expenditures | -42.4 | -120 | -87.3 | -99 | -42.7 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -4.12 | -236 | -9.44 | 53.6 | 20.5 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -46.5 | -356 | -96.7 | -45.4 | -22.1 |
| Financing Cash Flow Items | 973 | -49 | -18.4 | 57.2 | -7.98 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 754 | -101 | 11.6 | -119 | -101 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 820 | -188 | 80.4 | -93.4 | -140 |